Chee Chan, MD
Endocrinology, Diabetes & Metabolism · Mount Kisco, NYNPI 1306899745
Payments from drug & device makers
What this record shows
This record is dominated by other: $12 of the $12 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Baxter Healthcare. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in NY, where the typical reported total is $1,058.
Across 1 payment — averaging $12.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$12
What the payments were for
- Other$12100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 1 | $12 |
How this compares
$12 in reported general payments places this provider in the 0th percentile of 804 endocrinology, diabetes & metabolism providers in New York.
See all endocrinology, diabetes & metabolism providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 570 | $1,109,844 |
| MounjaroTirzepatide | 327 | $464,843 |
| JardianceEmpagliflozin | 215 | $305,185 |
| TrulicityDulaglutide | 150 | $241,390 |
| RybelsusSemaglutide | 79 | $124,133 |
| Tresiba Flextouch U-200Insulin Degludec | 55 | $107,986 |
| JanuviaSitagliptin Phosphate | 73 | $101,143 |
| ProliaDenosumab | 49 | $87,287 |
| Teriparatide | 29 | $77,361 |
| Tresiba Flextouch U-100Insulin Degludec | 80 | $64,400 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $46,367 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 81 | $45,167 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 31 | $38,690 |
| TradjentaLinagliptin | 24 | $35,211 |
| SynthroidLevothyroxine Sodium | 411 | $35,151 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Mount Kisco
- Caroline MesserMount Kisco$175K
- Robert BuschAlbany$2.7M
- Michael ShanikSmithtown$1.2M
- Ajay ChaudhuriBuffalo$888K
- Vinay KapoorManhasset$820K
- John BilezikianNew York$809K
- Barbara HirschManhasset$746K
- Martin GrajowerBronx$713K
- Anastasios ManessisNew York$656K
- Jonas LeibowitzYonkers$613K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.